about
European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemiaHepatocellular Toxicity Associated with Tyrosine Kinase Inhibitors: Mitochondrial Damage and Inhibition of Glycolysis.Histopathology and biochemistry analysis of the interaction between sunitinib and paracetamol in mice.Imatinib-induced liver cirrhosis in a patient with advanced gastrointestinal stroma tumor (GIST).Inhibition of paracetamol glucuronidation by tyrosine kinase inhibitors.Collateral damage: toxic effects of targeted antiangiogenic therapies in ovarian cancer.Hepatitis B reactivation in chronic myeloid leukemia patients receiving tyrosine kinase inhibitor.Drug interactions in childhood cancer.Imatinib-induced hyperbilirubinemia with UGT1A1 (*28) promoter polymorphism: first case series in patients with gastrointestinal stromal tumorDrug-drug interactions with imatinib: An observational study.Drug-induced acute liver failure: results of a U.S. multicenter, prospective study.Reduced exposure of imatinib after coadministration with acetaminophen in miceHepatic encephalopathy associated with cancer or anticancer therapy.Imatinib-induced fulminant liver failure in chronic myeloid leukemia: role of liver transplant and second-generation tyrosine kinase inhibitors: a case report.Fatal Outcome of Imatinib in a Patient with Idiopathic Hypereosinophilic Syndrome.Сase Report of Acute Toxic Imatinib-induced Hepatitis in a Patient with Chronic Myeloid Leukemia, Sulfa Allergy, and Rheumatoid Arthritis
P2860
Q26749324-E87FDB38-8696-45A0-9C5C-AFA77AD22D4FQ33794548-3339D72D-DD03-4D13-86BA-DBAAD66C6FEBQ34246117-4DFBA9F4-6B94-4851-983A-67A68FE9E2CAQ34276167-5B3D1D42-7997-486B-8C80-A3CFC3114BF5Q34996940-5E4A03A7-1EFB-44AF-9740-296E98AB9618Q35419004-7360BA0F-940A-4780-AF13-55CA89364C5DQ36654518-6B1C32C1-0DF2-4A9A-8122-C36005F3A276Q36898141-5610E2A6-587A-47CC-9DDF-AFE9AACC7C9EQ37308775-69D8D794-9822-48C6-85E6-5AA4DDF094FDQ37328934-43D729C7-A0F0-47A3-868C-C82DB7ED3EEDQ37711165-A6271C7B-CD58-4C2E-934E-0D4329C3B51EQ40729511-0AECB8A1-FC85-4916-A157-F09DA820FF22Q41111818-09AD6659-190A-4250-A22E-586C1EA23C92Q54122153-AA780E56-B445-4D87-A1EC-8988A5050F38Q55284980-9243D8F5-299B-418F-9259-F20ECABA752CQ57824060-F4FEC156-F2AD-4C8D-8C8C-8B5624C907C1
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Imatinib-induced fatal acute liver failure
@ast
Imatinib-induced fatal acute liver failure
@en
type
label
Imatinib-induced fatal acute liver failure
@ast
Imatinib-induced fatal acute liver failure
@en
prefLabel
Imatinib-induced fatal acute liver failure
@ast
Imatinib-induced fatal acute liver failure
@en
P2093
P2860
P356
P1476
Imatinib-induced fatal acute liver failure
@en
P2093
Adrián C Gadano
Alejandra G Villamil
Oscar G Mandó
Roberto Cacchione
Sebastián Marciano
P2860
P304
P356
10.3748/WJG.V13.I48.6608
P407
P50
P577
2007-12-01T00:00:00Z